Several issues have been identified regarding the sub-optimal sensitivity of PSA testing for PCa screening, which lead to unnecessary biopsies, overdiagnoses, and overtreatments [12]–[17]. This evidence concerns the gene KLK3 and posterior cortical atrophy.